250P Development and Validation of a 19-Feature Classifier That Predicts Response to Neoadjuvant Trastuzumab Emtansine (T-DM1) in Breast Cancer Patients

F. Pareja, E.D. Paul, B. Huraiová, N. Valková, N. Matyašovská, D. Gábrišová, S. Gubová, H. Ignačáková, T. Ondris, S. Bendíková, D. Lovíšek,M. Gala, I. Comino-Mendez,J.N. Kather, P. Cekan

Annals of Oncology（2024）

引用 0|浏览1